Lysophosphatidylcholine as a preferred carrier form for DHA to the brain

M. Lagarde, N. Bernoud, N. Brossard, D. Lemaitre-Delauney, Frank Thies, M. Croset, J. Lecerf

Research output: Contribution to journalArticle

136 Citations (Scopus)

Abstract

The metabolic fate of docosahexaenoic acid (DHA) was evaluated from its intake as a nutrient in triglycerides and phosphatidylcholines to its uptake by target tissues, especially the brain. Several approaches were used including the kinetics and tissue distribution of ingested C-13-labeled DHA, the incorporation of radiolabeled DHA injected as its nonesterified form compared to the fatty acid esterified in lysophosphatidylcholine (lysoPC), and the capacity of the two latter forms to cross a reconstituted blood-brain barrier (BBB) consisting of cocultures of brain-capillary endothelial cells and astrocytes. The results obtained allow us to raise the hypothesis that lysoPC may represent a preferred physiological carrier of DHA to the brain.

Original languageEnglish
Pages (from-to)201-204
Number of pages3
JournalJournal of Molecular Neuroscience
Volume16
Issue number2-3
DOIs
Publication statusPublished - 2001

Keywords

  • blood-brain barrier
  • fatty acid transport
  • lysophospholipids
  • omega-3 fatty acids
  • BOVINE RETINA
  • HUMAN PLASMA
  • FATTY-ACIDS
  • BIOSYNTHESIS
  • METABOLISM
  • BARRIER
  • ALBUMIN
  • CELLS
  • RAT
  • DHA

Cite this

Lagarde, M., Bernoud, N., Brossard, N., Lemaitre-Delauney, D., Thies, F., Croset, M., & Lecerf, J. (2001). Lysophosphatidylcholine as a preferred carrier form for DHA to the brain. Journal of Molecular Neuroscience, 16(2-3), 201-204. https://doi.org/10.1385/JMN:16:2-3:201

Lysophosphatidylcholine as a preferred carrier form for DHA to the brain. / Lagarde, M.; Bernoud, N.; Brossard, N.; Lemaitre-Delauney, D.; Thies, Frank; Croset, M.; Lecerf, J.

In: Journal of Molecular Neuroscience, Vol. 16, No. 2-3, 2001, p. 201-204.

Research output: Contribution to journalArticle

Lagarde, M, Bernoud, N, Brossard, N, Lemaitre-Delauney, D, Thies, F, Croset, M & Lecerf, J 2001, 'Lysophosphatidylcholine as a preferred carrier form for DHA to the brain', Journal of Molecular Neuroscience, vol. 16, no. 2-3, pp. 201-204. https://doi.org/10.1385/JMN:16:2-3:201
Lagarde, M. ; Bernoud, N. ; Brossard, N. ; Lemaitre-Delauney, D. ; Thies, Frank ; Croset, M. ; Lecerf, J. / Lysophosphatidylcholine as a preferred carrier form for DHA to the brain. In: Journal of Molecular Neuroscience. 2001 ; Vol. 16, No. 2-3. pp. 201-204.
@article{f628de1571744ed089a231a3551952ce,
title = "Lysophosphatidylcholine as a preferred carrier form for DHA to the brain",
abstract = "The metabolic fate of docosahexaenoic acid (DHA) was evaluated from its intake as a nutrient in triglycerides and phosphatidylcholines to its uptake by target tissues, especially the brain. Several approaches were used including the kinetics and tissue distribution of ingested C-13-labeled DHA, the incorporation of radiolabeled DHA injected as its nonesterified form compared to the fatty acid esterified in lysophosphatidylcholine (lysoPC), and the capacity of the two latter forms to cross a reconstituted blood-brain barrier (BBB) consisting of cocultures of brain-capillary endothelial cells and astrocytes. The results obtained allow us to raise the hypothesis that lysoPC may represent a preferred physiological carrier of DHA to the brain.",
keywords = "blood-brain barrier, fatty acid transport, lysophospholipids, omega-3 fatty acids, BOVINE RETINA, HUMAN PLASMA, FATTY-ACIDS, BIOSYNTHESIS, METABOLISM, BARRIER, ALBUMIN, CELLS, RAT, DHA",
author = "M. Lagarde and N. Bernoud and N. Brossard and D. Lemaitre-Delauney and Frank Thies and M. Croset and J. Lecerf",
year = "2001",
doi = "10.1385/JMN:16:2-3:201",
language = "English",
volume = "16",
pages = "201--204",
journal = "Journal of Molecular Neuroscience",
issn = "0895-8696",
publisher = "Humana Press",
number = "2-3",

}

TY - JOUR

T1 - Lysophosphatidylcholine as a preferred carrier form for DHA to the brain

AU - Lagarde, M.

AU - Bernoud, N.

AU - Brossard, N.

AU - Lemaitre-Delauney, D.

AU - Thies, Frank

AU - Croset, M.

AU - Lecerf, J.

PY - 2001

Y1 - 2001

N2 - The metabolic fate of docosahexaenoic acid (DHA) was evaluated from its intake as a nutrient in triglycerides and phosphatidylcholines to its uptake by target tissues, especially the brain. Several approaches were used including the kinetics and tissue distribution of ingested C-13-labeled DHA, the incorporation of radiolabeled DHA injected as its nonesterified form compared to the fatty acid esterified in lysophosphatidylcholine (lysoPC), and the capacity of the two latter forms to cross a reconstituted blood-brain barrier (BBB) consisting of cocultures of brain-capillary endothelial cells and astrocytes. The results obtained allow us to raise the hypothesis that lysoPC may represent a preferred physiological carrier of DHA to the brain.

AB - The metabolic fate of docosahexaenoic acid (DHA) was evaluated from its intake as a nutrient in triglycerides and phosphatidylcholines to its uptake by target tissues, especially the brain. Several approaches were used including the kinetics and tissue distribution of ingested C-13-labeled DHA, the incorporation of radiolabeled DHA injected as its nonesterified form compared to the fatty acid esterified in lysophosphatidylcholine (lysoPC), and the capacity of the two latter forms to cross a reconstituted blood-brain barrier (BBB) consisting of cocultures of brain-capillary endothelial cells and astrocytes. The results obtained allow us to raise the hypothesis that lysoPC may represent a preferred physiological carrier of DHA to the brain.

KW - blood-brain barrier

KW - fatty acid transport

KW - lysophospholipids

KW - omega-3 fatty acids

KW - BOVINE RETINA

KW - HUMAN PLASMA

KW - FATTY-ACIDS

KW - BIOSYNTHESIS

KW - METABOLISM

KW - BARRIER

KW - ALBUMIN

KW - CELLS

KW - RAT

KW - DHA

U2 - 10.1385/JMN:16:2-3:201

DO - 10.1385/JMN:16:2-3:201

M3 - Article

VL - 16

SP - 201

EP - 204

JO - Journal of Molecular Neuroscience

JF - Journal of Molecular Neuroscience

SN - 0895-8696

IS - 2-3

ER -